Biolex Therapeutics — Phase II Facility Expansion Project, Pittsboro, NC USA - Special Merit Recognition
Biolex Therapeutics’ facility located in Pittsboro, North Carolina, USA has been selected for special merit recognition for its Pittsboro Phase II Facility Expansion project. Biolex Therapeutics applies its drug development capabilities and expertise to commercialize complex proteins and monoclonal antibodies that until now have been impossible or very expensive to develop through traditional means. Biolex has an extensive, multi-protein strategic alliance with Centocor and collaborations with other pharmaceutical/biotech companies including Medarex, MedImmune, and OctoPlus. The company is also advancing a proprietary pipeline of product candidates including Locteron, a next-generation controlled-release form of alfa interferon. By emphasizing project simplicity, the GMP facility was completed from the beginning of design through IQ/OQ validation in only five months. Additionally, the project was delivered under budget, with no safety incidents, and with superior quality.